Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...
William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The main driver of the rating is the stability of the management team. Specifically, the fund has not seen a manager ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback